Kailera Therapeutics raised $625M in its IPO, ranking among the biggest ever biotech IPOs and surpassing Moderna's 2018 debut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results